Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 34:374-380
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, K.
Right arrow Articles by Yokoyama, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, K.
Right arrow Articles by Yokoyama, M.

CLINICAL STUDIES

Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy

Kazumasa Adachi, MDa, Yoshio Ohnishi, MDa, Takashi Shima, MDa, Kouhei Yamashiro, MDa, Asumi Takei, MDa, Nami Tamura, MDa and Mitsuhiro Yokoyama, MDa

a First Department of Internal Medicine, Kobe University School of Medicine, Kobe, Japan

Manuscript received August 6, 1998; revised manuscript received March 6, 1999, accepted April 14, 1999.

Reprint requests and correspondence: Dr. Yoshio Ohnishi, The First Department of Internal Medicine, Kobe University School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
ohnishi{at}med.kobe-u.ac.jp

OBJECTIVES

The aim of this study was to clarify the clinical significance and the determinant of microvolt-level T-wave alternans (TWA) in patients with dilated cardiomyopathy (DCM).

BACKGROUND

The prevention of sudden death in patients with DCM remains the therapeutic target. T-wave alternans has been proposed as a powerful tool for identification of patients at high risk for ventricular arrhythmias and sudden death in coronary artery disease.

METHODS

In 58 DCM patients, TWA was measured during bicycle exercise testing using a CH 2000 system (Cambridge Heart, Bedford, Massachusetts). The New York Heart Association class, signal-averaged electrocardiogram, QT dispersion, left ventricular end-diastolic diameter (LVDd) and percent fractional shortening detected by echocardiogram and the grade of the ventricular arrhythmia were obtained in all patients.

RESULTS

T-wave alternans was positive in 23 patients (TWA+ group), negative in 25 (TWA– group) and indeterminate in 10. Univariate analysis showed that the percentage of patients with ventricular tachycardia (VT) and the LVDd in the TWA+ group was significantly higher than those in the TWA– group (61% vs. 8%, p < 0.001 and 65 ± 11 mm vs. 58 ± 8 mm, p < 0.05, respectively). The sensitivity, specificity and predictive accuracy of TWA for VT were 88%, 72% and 77%, respectively. Multivariate analysis showed that the presence of VT was a major independent determinant of TWA in patients with DCM (p = 0.003).

CONCLUSIONS

T-wave alternans was closely related to VT in patients with DCM. T-wave alternans is a useful noninvasive test for identifying high risk patients with DCM who have VT.

Abbreviations and Acronyms
  DCM = dilated cardiomyopathy
  %FS = percent fractional shortening
  HCM = hypertrophic cardiomyopathy
  LAS 40 = duration of the low amplitude (<40 Hz) signals of the terminal filtered QRS complex
  LVDd = left ventricular end-diastolic diameter
  NYHA = New York Heart Association
  QTd = QT dispersion
  RMS 40 = root mean square voltage of the terminal 40 ms of the filtered QRS complex
  SAECG = signal-averaged electrocardiogram
  TWA = T-wave alternans
  VF = ventricular fibrillation
  VT = ventricular tachycardia




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. M. Narayan, J. D. Bayer, G. Lalani, and N. A. Trayanova
Action Potential Dynamics Explain Arrhythmic Vulnerability in Human Heart Failure A Clinical and Modeling Study Implicating Abnormal Calcium Handling.
J. Am. Coll. Cardiol., November 25, 2008; 52(22): 1782 - 1792.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Ikeda, H. Yoshino, K. Sugi, K. Tanno, H. Shimizu, J. Watanabe, Y. Kasamaki, A. Yoshida, and T. Kato
Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction: Results of a Collaborative Cohort Study
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2268 - 2274.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. M. Narayan
T-Wave Alternans and the Susceptibility to Ventricular Arrhythmias
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 269 - 281.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. K. Gehi, R. H. Stein, L. D. Metz, and J. A. Gomes
Microvolt T-Wave Alternans for the Risk Stratification of Ventricular Tachyarrhythmic Events: A Meta-Analysis
J. Am. Coll. Cardiol., July 5, 2005; 46(1): 75 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. D. Nearing and R. L. Verrier
Tracking cardiac electrical instability by computing interlead heterogeneity of T-wave morphology
J Appl Physiol, December 1, 2003; 95(6): 2265 - 2272.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
S. H. Hohnloser, T. Klingenheben, D. Bloomfield, O. Dabbous, and R. J. Cohen
Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2220 - 2224.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. D. Nearing and R. L. Verrier
Progressive Increases in Complexity of T-Wave Oscillations Herald Ischemia-Induced Ventricular Fibrillation
Circ. Res., October 18, 2002; 91(8): 727 - 732.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. A. Armoundas, G. F. Tomaselli, and H. D. Esperer
Pathophysiological basis and clinical application of T-wave alternans
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 207 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. D. Nearing and R. L. Verrier
Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy
J Appl Physiol, February 1, 2002; 92(2): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Kitamura, Y. Ohnishi, K. Okajima, A. Ishida, E. Galeano, K. Adachi, and M. Yokoyama
Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 295 - 300.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. Kovach, B. D. Nearing, and R. L. Verrier
Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1719 - 1725.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. G. Hennersdorf, V. Niebch, C. Perings, and B.-E. Strauer
T Wave Alternans and Ventricular Arrhythmias in Arterial Hypertension
Hypertension, February 1, 2001; 37(2): 199 - 203.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Ikeda, T. Sakata, M. Takami, N. Kondo, N. Tezuka, T. Nakae, M. Noro, Y. Enjoji, R. Abe, K. Sugi, et al.
Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction: A prospective study
J. Am. Coll. Cardiol., March 1, 2000; 35(3): 722 - 730.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement